Dukes Prevents Class Cert. in Nexium MDL, AstraZeneca Says

AstraZeneca PLC and several generic-drug makers facing multidistrict antitrust litigation alleging they unlawfully delayed the market entry of a generic form of Nexium told a Massachusetts federal judge Monday that a "sprawling class" of the ...read more

  • Tags: